Ranibizumab for retinal neovascularization

Rodrigo Jorge; Rodrigo S. Oliveira; Andre Messias; Felipe P. Almeida; Mario L. Strambe; Rogério A. Costa; Ingrid U. Scott

doi:10.1016/j.ophtha.2010.12.025

Ranibizumab for retinal neovascularization

Rodrigo Jorge, Rodrigo S. Oliveira, Andre Messias, Felipe P. Almeida, Mario L. Strambe, Rogério A. Costa, Ingrid U. Scott

Research output: Contribution to journal › Letter › peer-review

12 Scopus citations

Original language	English (US)
Pages (from-to)	1004-1004.e1
Journal	Ophthalmology
Volume	118
Issue number	5
DOIs	https://doi.org/10.1016/j.ophtha.2010.12.025
State	Published - May 2011

All Science Journal Classification (ASJC) codes

Ophthalmology

Access to Document

10.1016/j.ophtha.2010.12.025

Cite this

@article{517e791d3d2a425eaa7631c46a5f5ac0,

title = "Ranibizumab for retinal neovascularization",

author = "Rodrigo Jorge and Oliveira, {Rodrigo S.} and Andre Messias and Almeida, {Felipe P.} and Strambe, {Mario L.} and Costa, {Rog{\'e}rio A.} and Scott, {Ingrid U.}",

year = "2011",

month = may,

doi = "10.1016/j.ophtha.2010.12.025",

language = "English (US)",

volume = "118",

pages = "1004--1004.e1",

journal = "Ophthalmology",

issn = "0161-6420",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Ranibizumab for retinal neovascularization

AU - Jorge, Rodrigo

AU - Oliveira, Rodrigo S.

AU - Messias, Andre

AU - Almeida, Felipe P.

AU - Strambe, Mario L.

AU - Costa, Rogério A.

AU - Scott, Ingrid U.

PY - 2011/5

Y1 - 2011/5

UR - http://www.scopus.com/inward/record.url?scp=79955600686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955600686&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2010.12.025

DO - 10.1016/j.ophtha.2010.12.025

M3 - Letter

C2 - 21539985

AN - SCOPUS:79955600686

SN - 0161-6420

VL - 118

SP - 1004-1004.e1

JO - Ophthalmology

JF - Ophthalmology

IS - 5

ER -

Ranibizumab for retinal neovascularization

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this